[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-DYN":3,"homepage-market-summary":30,"stock-news-DYN":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"DYN","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Dyne Therapeutics, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.","258","Waltham, MA",false,{"close":16,"open":17,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},15.2,16.03,15.085,15.82,-0.62,-3.92,2497159.775626,26850,15.2958,27.305,12.43,2408948.19694516,18.6,1518,{"status":31,"indices":32,"watchlist":76,"sectors":98,"benchmarks":154},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":14,"sparkline":75,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":39,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":39,"sparkline":90,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":39,"sparkline":97,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":39},"Technology","XLK",1.01,199.81,{"name":105,"etf":106,"change":107,"price":108,"is_up":39},"Financials","XLF",0.06,53.49,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":39},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":132,"price":133,"is_up":39},"Industrials","XLI",0.78,169.95,{"name":135,"etf":136,"change":137,"price":138,"is_up":39},"Materials","XLB",0.66,48.86,{"name":140,"etf":141,"change":142,"price":143,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":39},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":89,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},18,[175,181,187,193,199,205,211,216,222,228,234,240,246,251,256,261,267,272],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"Wall Street Weighs Impact On DYN Stock Post Novartis’ Phase 3 Failure — RBC Says These Key Differences Could Lead To Better Outcomes - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxOMHppZFdkUGE4bU5rZUNEUzM0ampickd1YkYwUHJ1ZTdDM2FGQVpfb3ZJck9HZm92R09weHktd3Z3X2JoTWJvZW01ZFRXbDdMaDlHdUNLQ0NfcFZXT1RuQ2xhNXkzTXM0ZU12VDVLRlp3c2xXSnlzOVJLYmdTNVB6cjB3YWJzdzhlSUtJbGxVaks4WlVnZElaRlVJcllFbGlCNUpXMHlFM1N6bWtyQjJ1MlgxNzRGdnc?oc=5","Fri, 02 Oct 2026 23:14:13 GMT","Wall Street Weighs Impact On DYN Stock Post Novartis’ Phase 3 Failure — RBC Says These Key Differences Could Lead To Better Outcomes Stocktwits","Stocktwits",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Dyne Therapeutics stock rises on positive DM1 trial results - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikAFBVV95cUxOZEtRX2VrNFJQTTA3c3hsbXFDbHBRTkFVbXFRamc4bXdmZjNiZ3FidXZJUi0zY1EzUG82LTVubVFVNHRpVU1DSnJTeFZyOThxbk1VelltUV9YcTFaSk1jVTRIMlM5ZmRNUVl2VjlrYlFIWTdlc1B6blJSamZOUGNqczMxZjdUajJwVS1rWXVlMEU?oc=5","Tue, 29 Sep 2026 21:24:12 GMT","Dyne Therapeutics stock rises on positive DM1 trial results Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"After a year, Dyne trial participants showed better walking-test times and muscle strength - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxOSTgzc3Y0WHZodWRVMXJLSXhZM1pLNEV0UkVJOHd0VzJrakpfVWFnR3NWRmFfaWpOZzJBTXdPNGZXYlNjM0NxNGZWY2ptVlNESFRzb1hrNTFrbVdEdzhRbnhnd0dmczdHMXhOYzVSVWlhU0poelpnX1lZekZCbFpHUVJZbF9YRFNjQzBQOGRVb0s1QTl2YW5jZHltbTczY1BzN01HU29yTC1LUHdEaHJ3NzF3eU9HNWI4LU5TMA?oc=5","Tue, 29 Sep 2026 20:05:00 GMT","After a year, Dyne trial participants showed better walking-test times and muscle strength Stock Titan","Stock Titan",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"Dyne: Recent Price Drop On Rival's DM1 Data Creates (Risky) 'Buy The Dip' Scenario (DYN) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxONUtuWXVwdG9pclo5TUI4UzFRMUU4S0NrSDluSkVNRjg3VkVjcVpVeWo2Y2I5VVJXT2d0eTAxa0tsUHBLdDJSMU1yUWxsUW5ORm9kRVd3SVdQR2dVSGlSdHM5XzNlcmlwWkt2b215cnBSRmM1LUlHcHpiLWZfZ0k2cXU1VjhrQXBYZ3M3VVFzX1hnMTBHN0ZLaV9GVnNlZ0ZvYVpwcS1fWjMxS2dPTld3b0QwdUE2Zy1C?oc=5","Wed, 30 Sep 2026 17:30:02 GMT","Dyne: Recent Price Drop On Rival's DM1 Data Creates (Risky) 'Buy The Dip' Scenario (DYN) Seeking Alpha","Seeking Alpha",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Is Dyne Therapeutics (DYN) Undervalued Following New ACHIEVE Trial Data Presentations? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Tue, 22 Sep 2026 00:42:13 GMT","Is Dyne Therapeutics (DYN) Undervalued Following New ACHIEVE Trial Data Presentations? Simply Wall Street","Simply Wall Street",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"DYN Maintained by HC Wainwright & Co. -- Price Target Lowered to $32 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxOWXVCVTFFNTRXTGpCMlBhZHhGWERkcWV5cGt4RWlWdHVLdElFbjF4UDJMUUxIdTlucjlUSlhCRUU4aGdnZHNCUDhlckttaGNPUjNsMEk1UmRzYS1uV2pZTlJEcFkzblpyM3N1YTRpQzFvb3RHTlU5RFQ2d1VUU2xVQURiRUh2NU5ZT2VVTUR2dmNyeXVya2VxaDhlNlpNTEhDSXc?oc=5","Wed, 30 Sep 2026 11:18:29 GMT","DYN Maintained by HC Wainwright & Co. -- Price Target Lowered to $32 GuruFocus","GuruFocus",{"title":212,"link":213,"pubDate":214,"description":215,"source":180},"Why DYN Shares Are Down 10% After-Hours? Day After An FDA Win, Another Announcement Rocks Stock - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi7AFBVV95cUxQT1p1ZGZVRE5tZ0hYbVluMVJMQ3dHUkNPZEp5UDJ3dHMwZTFzMkxHTXlxdDUwQVpDSzZuanFYcGMtUWJGbjVKOVpDNDBPUTBkbXJzeEVjZ2M3dmFDdng5TTJCcnlLOF85bDVnRkx4bjFxcERmVVQ4Y3BpTVR4TDJCN21hdU5rbGNXSjY5MnVOcGxVWmZFX2dTWFZoTGZwYllBUGpXVkVBUWExVmMwTlBZNDNFdXhQUFNvb0pUVVNzM3U1ZFhzdGVLM3Z5OXdkNkJXRWRHb1VuaWZrUXBNWFN0VjV3a3pPc1REUmNOdQ?oc=5","Fri, 02 Oct 2026 18:52:12 GMT","Why DYN Shares Are Down 10% After-Hours? Day After An FDA Win, Another Announcement Rocks Stock Stocktwits",{"title":217,"link":218,"pubDate":219,"description":220,"source":221},"Piper Sandler Reaffirms Their Buy Rating on Dyne Therapeutics (DYN) - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi4wFBVV95cUxOY0w0RmU2Q0tCOFppeFJZdk1wbnBQX1NFZGNLSjdDbTZqeEdpaGM2NEpqYVdCQ3pObTFmMi1FcGlnZzFsdnh1VXpQRWZ6a2d5U3lET0REMlFWeEtQa1BtMklBOGdaZG9vUnBBSjlVdTYwd0lEd3VxdXR6cGZlUWhlMWVweTByWGt1dVdvamlLOTZwZFhWQVhLLUdqN0lrMkJDcVptVV9KX3ZoMkJLUjB2elZTbzJQdmc4ZWU1ZzktLTh3SHhIdHBCSlpsUGVtWVNCU0hGUlUycHNIdVpZZm1aTmlzVQ?oc=5","Wed, 30 Sep 2026 11:04:00 GMT","Piper Sandler Reaffirms Their Buy Rating on Dyne Therapeutics (DYN) The Globe and Mail","The Globe and Mail",{"title":223,"link":224,"pubDate":225,"description":226,"source":227},"(DYN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixwFBVV95cUxPLVhjTkp5M3R1RVpzMEdrTzdoVlpWbVBQcmFqdklPOGgxVnVwSjEtdlJ4TEtJVE8yQ28yLVB5VTJ2M1ZiZmM3bkZVenE3U0RaNXBiNEpkZFpCeW1vNkRZMDByeUt1SjVGeThndEtjalg0X0ZHQU1tcFVZM2FMVmZESExkYkNUTi1vZUg3dzBYU193Q3RHaUlXWks1WVQ3Ui1kYWVpbGdLLW5qVGpJcFpoWlNmd1lkWnYxeVZ6SmxLMXlINHNRdUhB?oc=5","Thu, 01 Oct 2026 05:10:01 GMT","(DYN) Movement Within Algorithmic Entry Frameworks Stock Traders Daily","Stock Traders Daily",{"title":229,"link":230,"pubDate":231,"description":232,"source":233},"Wainwright cuts Dyne Therapeutics stock price target on DM1 assumptions - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxNTllieUlkajlObzB3Y2hDTmtvaFRKVUtIdVJwSnRxbDBOMFRreTgyaWVRZnpWYnNMbWdTYmtFOEluYllCZHp6bVVRaDZ1ckgwWjN2TmxRa3VNTlBZQkJVWEZicHp4aU1BdWVzbXdnTUZmUzN5TllESlVrem8teHNRWEc1Tkw1UV9GU3BZaXRramFKRGVoajFBWHNtYlZ1TFhnQVVVYVN2S0syc05Qb2g1bi1EX3Y3eGY5V2d2TDVrbFpRVUhyY3Y3MU16SQ?oc=5","Wed, 30 Sep 2026 12:26:40 GMT","Wainwright cuts Dyne Therapeutics stock price target on DM1 assumptions Investing.com","Investing.com",{"title":235,"link":236,"pubDate":237,"description":238,"source":239},"BNPPF Private Harm Dyn Class Sel 1 Dis (0P0001BV2R.F) stock price, news, quote and history - Yahoo Finance UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiakFVX3lxTE92RENyZDN2WEs5VHJ0QkFPOEVwTUd3aXVxVUN3Y3NHUHpwSDRnMnFUby1fYWRid0FaR0p0XzVJbmRCc25MejVPOHhIYzNNZUNCcEhIdGVoZTBDbk5kdERwNmtZc3RrdFhGd3c?oc=5","Tue, 29 Sep 2026 20:00:00 GMT","BNPPF Private Harm Dyn Class Sel 1 Dis (0P0001BV2R.F) stock price, news, quote and history Yahoo Finance UK","Yahoo Finance UK",{"title":241,"link":242,"pubDate":243,"description":244,"source":245},"Chardan Capital maintains Buy rating on Dyne Therapeutics, $38 price target - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0AFBVV95cUxNdVkzUzNmRU11aTY3TzR0LTJLVFZfb1lLb2dZYUlGc0owSTliOEdFQW93TzZoRkNUb3JSSEluOFZPZ191aFVBZmgzQk1Va2VyTFgzUUc2OWxYRV8yTEh5SktJVWpQOWQ2aEc3dW5OT2FqRk9qSXd1d1VycEJSNUt2UFNiUWVuQW4tQURVWkRZRE05ZVJXN2NzNFpxRzBsejZrMmktOGV3ZkJocGZfZzV5MXNpdXduU0VBcUlGdndwX3RFMkJIVGttLWFlS0VnME5P?oc=5","Wed, 30 Sep 2026 12:00:12 GMT","Chardan Capital maintains Buy rating on Dyne Therapeutics, $38 price target TradingView","TradingView",{"title":247,"link":248,"pubDate":249,"description":250,"source":204},"Is Dyne Therapeutics (DYN) A Bargain After ACHIEVE Trial Data? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 30 Sep 2026 08:23:26 GMT","Is Dyne Therapeutics (DYN) A Bargain After ACHIEVE Trial Data? Simply Wall Street",{"title":252,"link":253,"pubDate":254,"description":255,"source":192},"CytoDyn (CYDY) amends two registrations covering 279M and 278M common shares to remove what remains unsold. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilwFBVV95cUxPNDh0ZHZETGx0YnZ4NUg0ZklSdy1YSXpIeG5LaHBqQ2oydVNZYmVacTdwUFBzZHZDRmVWR1NLM1d1eHBJRDZGelc5Q2lPUU5OVjgteklkQjRqaHA2eV9tbUhYZjdxV2JIRUVtY2htNnpLLXhnMFlENUtJZk1QZ0Z5QnlNeUlhanBlbU5GYTdGMElxdC1zQl9v?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","CytoDyn (CYDY) amends two registrations covering 279M and 278M common shares to remove what remains unsold. Stock Titan",{"title":257,"link":258,"pubDate":259,"description":260,"source":221},"Analysts Offer Insights on Healthcare Companies: Medios AG (OtherMEDOF) and Dyne Therapeutics (DYN) - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijAJBVV95cUxPRV9fYzB2Wk85V3p6bm40a2ljVTlGdGZkUTQxNDBpaHNCcGVGNHNlVnRuVjRKSlJyZzYzbi1PRE50RkowWGFsMUFFTzRjd2lCck1aMUVZay0tVWg4NFV1NWQzZ0ZCOWN0ZldUckFuODNmd08xZWM4REtqSzY4QVRmTU5YQUZnOXVjOWFIMkJxdGhHUWYtT2lpZ0xzci00MGlpejN3RF9hbjlnQ3NINzhHQkFBbDJRWnFRMVhhUWhSX0c5c29WNFNBdWNNZnhmT3hSRnNzeEl6S0dNZHZtczBhOHdEV01YcW9UVFd4eGt1bGlZWVRRM0FDTzVFNDkyajhBQmVOY0w3VmhubWt5?oc=5","Thu, 01 Oct 2026 12:40:00 GMT","Analysts Offer Insights on Healthcare Companies: Medios AG (OtherMEDOF) and Dyne Therapeutics (DYN) The Globe and Mail",{"title":262,"link":263,"pubDate":264,"description":265,"source":266},"Jefferies reiterates Dyne Therapeutics stock rating on trial data By Investing.com - in.investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxPN01ZRlVMTk9fZlE3MURJWC1WWklKdkdOaHM5YThkaGt5eVRiZVFmU2RVTW9KTzBXekNLMjV6eFB2WTUxc1UwWlRQYTVLZ0F5dUR2aTA4c1c2WF96cUxaSXBYQnRNOFg4RkMwdTNGR3V6X2dyMHdSX1NzbmdYZXA5b2tWb3N2RWtJMjViV0EzMXRvQ0NtR1k4VGtyZ21udmdUX05lTlJub0RhdGd3X2ZHYTlmZzFjelFDNVhaOVRsUjlnY2VO?oc=5","Wed, 30 Sep 2026 10:37:19 GMT","Jefferies reiterates Dyne Therapeutics stock rating on trial data By Investing.com in.investing.com","in.investing.com",{"title":268,"link":269,"pubDate":270,"description":271,"source":180},"SRPT Stock Drops 4% As Citi Flags Potentially Stronger Rival In Duchenne Space - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2AFBVV95cUxOMVlrWDktTVY1R082alh5azZDeGxqMGNrTHV2SkR0dldFUHZFb3JwZHFrWUJIbzRaZlR6bEVxalRDckhIdlBvZExTOFlvd0VLVUtnV2JPR19TTHpNX3hqVS1JR3g1RHB1RzJTSU5sUVFWMnNYVFhWSmRYNG9oWlNnLXF6OHdxRnZIRnpleUdTLTVQUkVfV284LUV6RndkaDlQWnhiSjVsZzFRUjhRaHdTZTQxbXdic010dlEzd0JTb1ZjODB5YU1STFNKVjkwaE54UkkxbkJ2V0w?oc=5","Sun, 04 Oct 2026 03:44:42 GMT","SRPT Stock Drops 4% As Citi Flags Potentially Stronger Rival In Duchenne Space Stocktwits",{"title":273,"link":274,"pubDate":275,"description":276,"source":277},"Cantor Fitzgerald reiterates Dyne Therapeutics stock rating By Investing.com - Investing.com UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxNS0VwdHlVQTJMNHNGbDZFMDJGcGRfbkZQbkRvVkhNWkpDMnlpS3N4YU5aS2V1TnIySEZDQzZqVV9iTU9UX2dxY2dOaTF0NHA2ZG5WWU55LVdtUjY0ZVZVTkxOUlVhUFpjZm96dE9fWFctR2lIQWlubVBlZkVyazh6S3VoamNVTlRxaEtvTjFraTZmZEJhVmo1SkdsY1RMamhlcWpyMXQteU5zSVRZeXVJdnRrM3NFb0txSmVFbg?oc=5","Wed, 30 Sep 2026 11:52:00 GMT","Cantor Fitzgerald reiterates Dyne Therapeutics stock rating By Investing.com Investing.com UK","Investing.com UK"]